Literature DB >> 18227396

Lipid management to reduce cardiovascular risk: a new strategy is required.

H Robert Superko1, Spencer King.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18227396     DOI： 10.1161/CIRCULATIONAHA.106.667428

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  27 in total

Review 1.  Therapeutic strategies to deplete macrophages in atherosclerotic plaques.

Authors:  Inge De Meyer; Wim Martinet; Guido R Y De Meyer
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

Review 2.  Is it LDL particle size or number that correlates with risk for cardiovascular disease?

Authors:  H Robert Superko; Radhika R Gadesam
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 3.  Genetics and personalized medicine--a role in statin therapy?

Authors:  Jaideep Patel; Thura Abd; Roger S Blumenthal; Khurram Nasir; H Robert Superko
Journal:  Curr Atheroscler Rep       Date:  2014-01       Impact factor: 5.113

Review 4.  Novel metabolic biomarkers of cardiovascular disease.

Authors:  Majken K Jensen; Monica L Bertoia; Leah E Cahill; Isha Agarwal; Eric B Rimm; Kenneth J Mukamal
Journal:  Nat Rev Endocrinol       Date:  2014-09-02       Impact factor: 43.330

Review 5.  ApoCIII as a Cardiovascular Risk Factor and Modulation by the Novel Lipid-Lowering Agent Volanesorsen.

Authors:  Natalia A Rocha; Cara East; Jun Zhang; Peter A McCullough
Journal:  Curr Atheroscler Rep       Date:  2017-11-09       Impact factor: 5.113

6.  S447X variant of the lipoprotein lipase gene, lipids, and risk of coronary heart disease in 3 prospective cohort studies.

Authors:  Majken K Jensen; Eric B Rimm; Daniel Rader; Erik B Schmidt; Thorkild I A Sørensen; Ulla Vogel; Kim Overvad; Kenneth J Mukamal
Journal:  Am Heart J       Date:  2009-02       Impact factor: 4.749

Review 7.  Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia.

Authors:  Peter Alagona
Journal:  Vasc Health Risk Manag       Date:  2010-05-25

Review 8.  Low high-density lipoprotein cholesterol: current status and future strategies for management.

Authors:  Vibhuti Singh; Rakesh Sharma; Ajoy Kumar; Prakash Deedwania
Journal:  Vasc Health Risk Manag       Date:  2010-10-29

Review 9.  Triglycerides and risk for coronary artery disease.

Authors:  Patrick McBride
Journal:  Curr Atheroscler Rep       Date:  2008-10       Impact factor: 5.113

Review 10.  Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Authors:  Jesús Millán; Xavier Pintó; Anna Muñoz; Manuel Zúñiga; Joan Rubiés-Prat; Luis Felipe Pallardo; Luis Masana; Alipio Mangas; Antonio Hernández-Mijares; Pedro González-Santos; Juan F Ascaso; Juan Pedro-Botet
Journal:  Vasc Health Risk Manag       Date:  2009-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.